ucsf logobch logo

Mary J. Malloy, MD

Pediatric Endocrinology • EndocrinologyDirector, Pediatric Lipid Clinic
ucsf logobch logo

Mary J. Malloy, MD

Pediatric Endocrinology • EndocrinologyDirector, Pediatric Lipid Clinic

On this page

About me

Dr. Mary Malloy is a metabolism specialist who cares for adults and children with cholesterol and triglyceride disorders, which can lead to the narrowing of arteries and cause other conditions, such as heart attack, stroke or pancreatitis. She serves as co-director of UCSF's lipid clinic for adults and director of the pediatric lipid clinic, which she established in 1971.

Malloy earned her medical degree at UCSF. She completed her residency in pediatrics at the University of Washington and UCSF, followed by a fellowship in pediatrics at UCSF.

Malloy's research interests have included lipoprotein metabolism, management of lipoprotein disorders, and the genetics of heart disease and stroke. She is a senior investigator in the UCSF Cardiovascular Research Institute. She has published widely on her research and clinical experience in journals and books.

Malloy is a fellow of the American Heart Association and a diplomate of the American Board of Clinical Lipidology. Physicians in the U.S. and abroad consult her on the diagnosis and management of complex cases involving lipoprotein disorders in children.

Education & training

Fellowship

  • UCSF Medical Center - OMAG
  • Pediatrics, UCSF Graduate Medical Education

Residency

  • Pediatrics, UCSF Medical Center - OMAG

Degree

  • UCSF School of Medicine
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.